Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System (FIX-HF-5C2)
FIX-HF-5C2: Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%
Sponsor: Impulse Dynamics
A NA clinical study on CHF and Chronic Heart Disease, this trial is completed. The trial is conducted by Impulse Dynamics and has accumulated 9 data snapshots since 2017. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Feb 2020 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jan 2019 — Feb 2020 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 4 earlier versions
-
Sep 2018 — Jan 2019 [monthly]
Recruiting NA
-
Jun 2018 — Sep 2018 [monthly]
Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Recruiting NA
-
Dec 2017 — Mar 2018 [monthly]
Recruiting NA
First recorded
Oct 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Impulse Dynamics
For direct contact, visit the study record on ClinicalTrials.gov .